Hostname: page-component-7b9c58cd5d-6tpvb Total loading time: 0 Render date: 2025-03-15T07:56:46.733Z Has data issue: false hasContentIssue false

Impulsivity, dual diagnosis, and the structure of motivated behavior in addiction

Published online by Cambridge University Press:  29 July 2008

R. Andrew Chambers
Affiliation:
Department of Psychiatry, Indiana University School of Medicine, Institute of Psychiatric Research, Indianapolis, IN 46202. robchamb@iupui.edu
Rights & Permissions [Opens in a new window]

Abstract

Defining brain mechanisms that control and adapt motivated behavior will not only advance addiction treatment. It will help society see that addiction is a disease that erodes free will, rather than representing a free will that asks for or deserves consequences of drug-use choices. This science has important implications for understanding addiction's comorbidity in mental illness and reducing associated public health and criminal justice burdens.

Type
Open Peer Commentary
Copyright
Copyright © Cambridge University Press 2008

As nicely exhibited by Redish et al., we are converging on an understanding that addiction is a disease impacting specific brain systems that control and adapt motivated behavior. Evidence reported here, and continually mounting (Belin & Everitt Reference Belin and Everitt2008), paints an increasingly clear picture that addiction is not merely a vague notion of so-called psychological dependence or some unchecked need to feel good all the time. Rather, it is a disease of neurological character, involving brain systems and phenomenological themes reminiscent of Parkinson's or Huntington's disease. Like these diseases, addiction involves progressive changes to the basal ganglia, the primary neural system involved in the ordering and procedural memory of behavioral programming (Everitt & Robbins Reference Everitt and Robbins2005; Haber Reference Haber2003; Volkow et al. Reference Volkow, Wang, Telang, Fowler, Logan, Childress, Jayne, Ma and Wong2006). Perhaps it has taken us this long to appreciate addiction as a type of progressive cortical-striatal disease because it uniquely seems to involve functions of “free will” that many view as unapproachable as a biomedical topic of exploration. After all, Parkinson's and Huntington's are so obviously motoric in nature, and involuntary, whereas any action choice (i.e., to use a drug) appears voluntary, whether in the addict or in the drug-naive.

But now a new picture is emerging: While dorsal cortical-striatal systems govern the relatively inflexible execution of procedural motor programs (i.e., behavior), ventral cortical-striatal systems flexibly and hierarchically govern the ordering, prioritization, and selection of these dorsally represented programs (i.e., motivation) (Gerdeman et al. Reference Gerdeman, Partridge, Lupica and Lovinger2003; Haber et al. Reference Haber, Fudge and McFarland2000; Kelley Reference Kelley2004b; Yin & Knowlton Reference Yin and Knowlton2006). As facilitated by ever-changing environmental contingencies that provoke rapid changes in striatal dopamine transmission (Bardo et al. Reference Bardo, Donohew and Harrington1996; Finlay & Zigmond Reference Finlay and Zigmond1997; Spanagel & Weiss Reference Spanagel and Weiss1999), neuroplastic alterations spanning these striatal regions change the way ventral and dorsal compartments represent information and communicate with one another (Chambers et al. Reference Chambers, Bickel and Potenza2007; Graybiel Reference Graybiel1998; Hyman & Malenka Reference Hyman and Malenka2001). Thus, behavioral repertoires are dynamically evolving, highly complex structures, or maps, in which specific motor programs are like destinations interconnected by motivational routes (Chambers et al. Reference Chambers, Bickel and Potenza2007). Depending on developmental age, environmental conditions, or inherent individual attributes, cortical-striatal circuits that generate these motivational-behavioral repertoires are themselves physically changing in an unending attempt to provide the most adaptive mapping of behavioral organization of the individual to the external world (Chambers et al. Reference Chambers, Bickel and Potenza2007).

Equipped with this understanding, there is no need to equate a biomedical understanding of addiction with a hubristic claim that we can absolutely define all the physical mechanisms of “free will.” Who knows if we shall ever fully grasp the extreme complexity of human behavioral repertoires? But we can say that if this complexity is synonymous with “free will,” then addiction is a disease of neural systems that govern free will, in which the adaptive complexity of free will is reduced and compromised. Understanding this process mechanistically may actually be within our grasp.

Redish et al. rightly centralize a general concept of impaired decision-making in the pathophysiology of addiction. Of all contexts in which addiction vulnerability has been identified, two stand out most prominently: adolescent neurodevelopment and mental illness (Chambers et al. Reference Chambers, Taylor and Potenza2003; Kessler Reference Kessler2004). Notably, these contexts entail features that are associated with a general theme of impulsivity, whether it be couched in terms of “novelty-seeking,” “high risk-taking,” “poor judgment” or “decision-making,” or “behavioral inhibition deficits.” To suggest a succinct, yet inclusive formulation of impulsivity: it is an operational condition in which ventral cortical-striatal circuits consistently fail to produce adaptive mapping of behavioral organization onto the external world, despite normative intelligence. Of course, in normal adolescence, such impulsivity is actually quite adaptive, because developing healthy brains have the need and capacity for learning from their mistakes (Chambers & Potenza Reference Chambers and Potenza2003). But in mental illness, such capacities are episodically or chronically compromised into adulthood, and the mapping of behavioral organization is maladaptively reduced in complexity and/or relatively inflexible to change based on environmental demands.

Across the broad span of mental illnesses in which addiction comorbidity is robustly present (including schizophrenia, bipolar disorder, antisocial and borderline personality, post-traumatic stress disorder [PTSD], various impulse control disorders, and many others) (Kessler Reference Kessler2004), one or more of the following three brain regions are pathologically altered: the prefrontal cortex, the amygdala, and the hippocampus (Charney et al. Reference Charney, Nestler and Bunney1999). All of these areas normally and robustly send direct glutamatergic projections into the ventral striatum (Groenewegen et al. Reference Groenewegen, Wright, Beijer and Voorn1999; Haber Reference Haber2003; Swanson Reference Swanson2000). There, these projections not only cooperatively help generate and modulate a rich diversity of firing pattern representations spanning ventral striatal networks (representing motivational information), but they act in concert with, or are acted upon by dopamine, resulting in altered neural connectivity (Goto & Grace Reference Goto and Grace2005a; Hyman & Malenka Reference Hyman and Malenka2001; O'Donnell et al. Reference O'Donnell, Greene, Pabello, Lewis and Grace1999; Vanderschuren & Kalivas Reference Vanderschuren and Kalivas2000). Such plasticity likely instantiates the acquisition of new motivational representations contributing to a more complex, highly nuanced, and adaptive motivational repertoire that optimally directs behavioral programming. But, if one or more among the prefrontal cortex, the amygdala, or the hippocampus is compromised due to a pre-existing neurodevelopmental condition (i.e., mental illness), then the complexity and/or adaptive flexibility of the motivational-behavioral repertoire, as generated by striatal networks, is reduced (Chambers Reference Chambers2007). In other words, since limbic inputs to the ventral striatum are relatively impoverished, then the catalogue of motivational representations that may be generated by it are also impoverished in number, complexity, or changeability.

Although some dopamine-mediated neuroplasticity (and adaptive behavioral flexibility) persists that can produce real change in the motivational repertoire, such change may be abnormally limited to conditions or stimuli that produce particularly strong and/or prolonged dopamine (DA) signals (e.g., pharmacological actions of addictive drugs). Without, or before, addictive drug exposure, this situation is clinically perceived as impulsivity, poor decision-making, or other motivational disturbances of mental illness. Upon addictive drug exposure we have a massive epidemic of dual diagnosis (substance disorder comorbidity in mental illness) on our hands to the tune of greater than 50% of all mentally ill or drug-addicted patients seeking treatment (Dixon Reference Dixon1999; RachBeisel et al. Reference RachBeisel, Scott and Dixon1999). In the de-institutionalization era, no wonder we face such tremendous medical morbidity and mortality from addictions, and homelessness and criminal incarceration of the mentally ill (Lasser et al. Reference Lasser, Boyd, Woolhandler, Heimmerlstein, McCormick and Bor2000; Rosen et al. Reference Rosen, Rosenheck, Shaner, Eckman, Gamache and Krebs2002; Schmetzer Reference Schmetzer2006).

Consistent with these translational perspectives, animal modeling of dual diagnosis has demonstrated that if certain neurodevelopmental lesion models of mental illness are combined with addictive drug exposure, addiction vulnerability phenotypes are accentuated. For instance, neonatal ventral hippocampal lesions (a comprehensive animal model of schizophrenia) produce a host of biological changes involving prefrontal cortical and ventral striatal circuits (Goto & O'Donnell Reference Goto and O'Donnell2002; Lipska et al. Reference Lipska, Lerman, Khaing and Weinberger2003; Tseng et al. Reference Tseng, Lewis, Lipska and O'Donnell2007). These aspects correspond to increases in acquisition of cocaine self-administration, resistance to extinction, and drug-induced relapse of drug-seeking (Chambers & Self Reference Chambers and Self2002). The lesion also produces elevations of an impulsive approach to natural reward before drug exposure, and synergistic worsening of this trait after cocaine exposure in a manner not seen in control animals (Chambers et al. Reference Chambers, Jones, Brown and Taylor2005).

As suggested by Redish et al., identifying differential styles or mechanisms of impulsivity as predictive markers of addiction vulnerability, illness trajectory, or treatment options, is surely a next step for the field. Studying differential forms and patterns of dual diagnosis in both animal models and human populations should represent a major avenue of the exploration. This work will help us elucidate the extent to which the 10 decision-making vulnerabilities suggested by Redish et al. represent truly independent facets of addiction vulnerability or redundant manifestations of the same underlying principle. By determining which of these vulnerabilities carry the most weight of addiction liability in most people, we may arrive at a more parsimonious and “winning” theory of addiction.

ACKNOWLEDGMENT

This commentary is supported in part by The National Institute on Drug Abuse K08 DA019850–03.

References

Bardo, M. T., Donohew, R. L. & Harrington, N. G. (1996) Psychobiology of novelty seeking and drug seeking behavior. Behavioral Brain Research 77(1–2):2343.CrossRefGoogle ScholarPubMed
Belin, D. & Everitt, B. J. (2008) Cocaine-seeking habits depend upon dopamine-dependent serial connectivity linking the ventral and dorsal striatum. Neuron 57:432–41.CrossRefGoogle ScholarPubMed
Chambers, R. A. (2007) Animal modeling and neurocircuitry of dual diagnosis. Journal of Dual Diagnosis 3(2):1929.CrossRefGoogle ScholarPubMed
Chambers, R. A., Bickel, W. K. & Potenza, M. N. (2007) A scale-free systems theory of motivation and addiction. Neuroscience and Biobehavioral Reviews 31(7):1017–45.CrossRefGoogle ScholarPubMed
Chambers, R. A., Jones, R. M., Brown, S. & Taylor, J. R. (2005) Natural reward related learning in rats with neonatal ventral hippocampal lesions and prior cocaine exposure. Psychopharmacology 179(2):470–78.CrossRefGoogle ScholarPubMed
Chambers, R. A. & Potenza, M. N. (2003) Neurodevelopment, impulsivity, and adolescent gambling. Journal of Gambling Studies 19(1):5384.CrossRefGoogle ScholarPubMed
Chambers, R. A. & Self, D. W. (2002) Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: An animal model of dual diagnosis schizophrenia. Neuropsychopharmacology 27(6):889905.CrossRefGoogle ScholarPubMed
Chambers, R. A., Taylor, J. R. & Potenza, M. N. (2003) Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. American Journal of Psychiatry 160(6):1041–52.CrossRefGoogle ScholarPubMed
Charney, D. S., Nestler, E. J. & Bunney, B. S., eds. (1999) Neurobiology of mental illness. Oxford University Press.Google Scholar
Dixon, L. (1999) Dual diagnosis of substance abuse in schizophrenia: Prevalence and impact on outcomes. Schizophrenia Research 35 (Suppl.):S93100.CrossRefGoogle ScholarPubMed
Everitt, B. J. & Robbins, T. W. (2005) Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nature Neuroscience 8(11):1481–89.CrossRefGoogle ScholarPubMed
Finlay, J. M. & Zigmond, M. J. (1997) The effects of stress on central dopaminergic neurons: Possible clinical implications. Neurochemical Research 22(11):1387–94.CrossRefGoogle ScholarPubMed
Gerdeman, G. L., Partridge, J. G., Lupica, C. R. & Lovinger, D. M. (2003) It could be habit forming: Drugs of abuse and striatal synaptic plasticity. Trends in Neuroscience 26(4):184–92.CrossRefGoogle ScholarPubMed
Goto, Y. & Grace, A. A. (2005a) Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: Disruption by cocaine sensitization. Neuron 47(2):255–66.CrossRefGoogle ScholarPubMed
Goto, Y. & O'Donnell, P. (2002) Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. Journal of Neuroscience 22(20):9070–77.CrossRefGoogle Scholar
Graybiel, A. M. (1998) The basal ganglia and chunking of action repertoires. Neurobiology of Learning and Memory 70(1–2):119–36.CrossRefGoogle ScholarPubMed
Groenewegen, H. J., Wright, C. I., Beijer, A. V. & Voorn, P. (1999) Convergence and segregation of ventral striatal inputs and outputs. Annals of the New York Academy of Sciences 877:4963.CrossRefGoogle ScholarPubMed
Haber, S. N. (2003) The primate basal ganglia: Parallel and integrative networks. Journal of Chemical Neuroanatomy 26:317–30.CrossRefGoogle ScholarPubMed
Haber, S. N., Fudge, J. L. & McFarland, N. R. (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. Journal of Neuroscience 20(6):2369–82.CrossRefGoogle ScholarPubMed
Hyman, S. E. & Malenka, R. C. (2001) Addiction and the brain: The neurobiology of compulsion and its persistence. Nature Reviews Neuroscience 2:695703.CrossRefGoogle ScholarPubMed
Kelley, A. E. (2004b) Ventral striatal control of appetitive motivation: Role in ingestive behavior and reward related learning. Neuroscience and Biobehavioral Reviews 27:765–76.CrossRefGoogle ScholarPubMed
Kessler, R. C. (2004) The epidemiology of dual diagnosis. Biological Psychiatry 56:730–37.CrossRefGoogle ScholarPubMed
Lasser, K., Boyd, J. W., Woolhandler, S., Heimmerlstein, D., McCormick, D. & Bor, D. (2000) Smoking in mental illness: A population-based prevalence study. Journal of the American Medical Association 284(20):2606–10.CrossRefGoogle ScholarPubMed
Lipska, B. K., Lerman, D. N., Khaing, Z. Z. & Weinberger, D. R. (2003) The neonatal ventral hippocampal lesion model of schizophrenia: Effects on dopamine and GABA mRNA markers in the rat midbrain. European Journal of Neuroscience 18:30973104.CrossRefGoogle ScholarPubMed
O'Donnell, P., Greene, J., Pabello, N., Lewis, B. L. & Grace, A. A. (1999) Modulation of cell firing in the nucleus accumbens. Annals of the New York Academy of Sciences 877:157–75.CrossRefGoogle ScholarPubMed
RachBeisel, J., Scott, J. & Dixon, L. (1999) Co-occurring severe mental illness and substance use disorders: A review of recent research. Psychiatric Services 50(11):1427–34.CrossRefGoogle ScholarPubMed
Rosen, M. I., Rosenheck, R. A., Shaner, A., Eckman, T., Gamache, G. & Krebs, C. (2002) Veterans who may need a payee to prevent misuse of funds for drugs. Psychiatric Services 53(8):9951000.CrossRefGoogle Scholar
Schmetzer, A. D. (2006) Deinstitutionalization and dual diagnosis. Journal of Dual Diagnosis 3:95101.CrossRefGoogle Scholar
Spanagel, R. & Weiss, F. (1999) The dopamine hypothesis of reward: Past and current status. Trends in Neurosciences 22(11):521–27.CrossRefGoogle ScholarPubMed
Swanson, L. W. (2000) Cerebral hemisphere regulation of motivated behavior. Brain Research 886(1–2):113–64.CrossRefGoogle ScholarPubMed
Tseng, K. Y., Lewis, B. L., Lipska, B. K. & O'Donnell, P. (2007) Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biological Psychiatry 62:730–38.CrossRefGoogle Scholar
Vanderschuren, L. J. M. J. & Kalivas, P. (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology 151:99120.CrossRefGoogle ScholarPubMed
Volkow, N. D., Wang, G. J., Telang, F., Fowler, J. S., Logan, J., Childress, A. R., Jayne, M., Ma, Y. & Wong, C. (2006) Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. Journal of Neuroscience 26:6583–88.CrossRefGoogle ScholarPubMed
Yin, H. H. & Knowlton, B. J. (2006) The role of the basal ganglia in habit formation. Nature Reviews Neuroscience 7:464–76.CrossRefGoogle ScholarPubMed